Patent US5551427A successfully refreshed from Google Patents.
US5551427A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Implantable device for the effective elimination of cardiac arrhythmogenic sites
Assignee: Biocardia Inc
•
Filing: 1995-02-13
•
Granted: 1996-09-03
•
Expires: 2015-02-13
Abstract
Abstract An implantable devices for the effective elimination of an arrhythmogenic site from the myocardium is presented. By inserting small biocompatible conductors and/or insulators into the heart tissue at the arrhythmogenic site, it is possible to effectively eliminate a portion of the tissue from the electric field and current paths within the heart. The device would act as an alternative to the standard techniques for the removal of tissue from the effective contribution to the hearts electrical action which require the destruction of tissue via energy transfer (RF, microwave, cryogenic, etc.). This device is a significant improvement in the state of the art in that it does not require tissue necrosis. In one preferred embodiment the device is a non conductive helix that is permanently implanted into the heart wall around the arrhythmogenic site. In variations on the embodiment, the structure is wholly or partially conductive, the structure is used as an implantable substrate for anti arrhythmic, inflammatory, or angiogenic pharmacological agents, and the structure is deliverable by a catheter with a disengaging stylet. In other preferred embodiments that may incorporate the same variations, the device is a straight or curved stake, or a group of such stakes that are inserted simultaneously.
Inventors
- 👤 Peter A. Altman
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 09:44
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/05; A61N1/056; A61F; A61F2/00; A61N1/057; A61N1/0573
Claims Analysis
Total Claims: 30
Claim 1
Independent Claim
120 words
A medical device implantable in a heart, for treating arrhythmogenic sites in the heart, the device comprising: a electrically inactive structure having an exposed surface and biocompatible at least over the exposed surface, said structure adapted to be chronically implanted into cardiac tissue within a region substantially adjacent to an arrhythmogenic site in a heart, and, when so implanted, altering conduction properties of the cardiac tissue within said region; and wherein the structure incorporates a coupling means for releasably coupling the structure to a delivery device operable to deliver the structure to the region and implant the structure into the cardiac tissue, said coupling means operable to enable disengagement and removal of the delivery device after the structure is implanted.
Claim 2
Dependent Claim
120 words
A medical device implantable in a heart, for treating arrhythmogenic sites in the heart, the device comprising: a electrically inactive structure having an exposed surface and biocompatible at least over the exposed surface, said structure adapted to be chronically implanted into cardiac tissue within a region substantially adjacent to an arrhythmogenic site in a heart, and, when so implanted, altering conduction properties of the cardiac tissue within said region; and wherein the structure incorporates a coupling means for releasably coupling the structure to a delivery device operable to deliver the structure to the region and implant the structure into the cardiac tissue, said coupling means operable to enable disengagement and removal of the delivery device after the structure is implanted.
Claim 3
Dependent Claim
20 words
The device of claim 1 wherein: said structure is selected from a group consisting of helical bodies, stakes, and cages.
Claim 4
Dependent Claim
30 words
The device of claim 1 wherein: said structure is formed of biocompatible materials selected from the group consisting of polytetrafluoroethylene, expanded polytetrafluoroethylene, polyester, polyurethane, silicon, platinum, iridium, titanium, and MP35N.
Claim 5
Dependent Claim
66 words
The device of claim 1 wherein: said structure, at least over an outermost portion thereof that includes said exposed surface, is constructed of a biocompatible material selected from the group consisting of platinum black, titanium nitride, sintered platinum, roughened platinum, roughened MP35N, and roughened titanium, whereby the effective surface area of the structure is enhanced to augment electrical coupling of the structure and the cardiac tissue.
Claim 6
Dependent Claim
59 words
The device of claim 1 further including: a delivery catheter releasably coupled at a distal end thereof to said structure by said coupling means, adapted for intravascularly delivering the structure into the heart and to said region, and further operable at a proximal end thereof to at least partially embed the structure within said cardiac tissue at said region.
Claim 7
Dependent Claim
34 words
The device of claim 1 wherein: said structure includes means for delivering a predetermined pharmacological agent to said cardiac tissue at said region, for further altering conduction properties of said tissue within said region.
Claim 8
Dependent Claim
42 words
The device of claim 6 wherein: said structure includes a substrate coated with a non-conductive controlled release matrix less rigid than the substrate, with the controlled release matrix being at least partially embedded within said tissue when the structure is so implanted.
Claim 9
Dependent Claim
27 words
The device of claim 6 wherein: said predetermined pharmacological agent is selected from a group consisting of anti-arrhythmic agents, angiogenic growth factors, anti-inflammatory agents, and their combinations.
Claim 10
Dependent Claim
61 words
The device of claim 6 wherein: said structure includes a rigid core material forming a proximal head and a distal tip, and an insulative controlled release matrix covering the rigid core material between the head and the tip, to facilitate use of the structure for electrical mapping of said tissue when the structure is at least partially embedded into the tissue.
Claim 11
Dependent Claim
59 words
The device of claim 1 wherein: said structure includes a hollow core and a plurality of apertures from the hollow core open to the outer surface of the structure, a proximally located head in fluid communication with the hollow core, and a tube coupled to the head for supplying a pharmacological agent to the hollow core via the head.
Claim 12
Dependent Claim
36 words
The device of claim 10 wherein: said structure further includes a non-conductive controlled release matrix forming a coating over said apertures, for delivering said predetermined pharmacological agent to an innermost surface of said controlled release matrix.
Claim 13
Independent Claim
67 words
A method of locally altering electrical activity in cardiac tissue at a selected site in the region of the heart, including: measuring electrical activity in cardiac tissue, to identify a potential implantation site; introducing a first electrically inactive and biocompatible implantable device into the region of the heart, and at least partially embedding said first implantable device into cardiac tissue at the site to effect an implantation.
Claim 14
Independent Claim
67 words
A method of locally altering electrical activity in cardiac tissue at a selected site in the region of the heart, including: measuring electrical activity in cardiac tissue, to identify a potential implantation site; introducing a first electrically inactive and biocompatible implantable device into the region of the heart, and at least partially embedding said first implantable device into cardiac tissue at the site to effect an implantation.
Claim 15
Dependent Claim
107 words
The method of claim 12 further including: after said implantation, performing a plurality of electrical measurements in cardiac tissue proximate the site and, based on results of said electrical measurements, performing at least one of the following sub-steps: (i) determining that the implantation has successfully altered conduction properties as intended; (ii) based on a determination that the implantation has not successfully altered conduction properties as intended, removing and repositioning the first implantable device; and (iii) responsive to determining that the implantation has not successfully altered conduction properties as intended, embedding a second electrically inactive and biocompatible implantable device proximate the first implantable device and proximate said site.
Claim 16
Dependent Claim
40 words
The method of claim 13 further including: after said performing the plurality of electrical measurements and before performing said at least one substep, supplying a pharmacological agent via the first implantable device to cardiac tissue proximate the first implantable device.
Claim 17
Dependent Claim
36 words
The method of claim 13 further including: after said implantation and before said performing the plurality of electrical measurements, supplying a pharmacological agent via the first implantable device to cardiac tissue proximate the first implantable device.
Claim 18
Dependent Claim
32 words
The method of claim 12 further including: after said implantation of the first implantable device, supplying a pharmacological agent via the first implantable device to cardiac tissue proximate the first implantable device.
Claim 19
Dependent Claim
32 words
The method of claim 16 wherein: said supplying of a pharmacological agent comprises delivering the pharmacological agent from a source to the implantable device via a tube coupled to the implantable device.
Claim 20
Dependent Claim
65 words
The method of claim 12 wherein: said introducing the first implantable device comprises releasably attaching the first implantable device to a distal end of a catheter, using the catheter to intravascularly deliver the device to the implantation site, manipulating the catheter at a proximal end thereof to achieve said implantation, decoupling the catheter from the first implantable device and withdrawing the catheter after said implantation.
Claim 21
Independent Claim
115 words
An apparatus for locally modifying electrical action within a heart, comprising: an implantable electrically inactive device including tissue penetration means and a coupling means; and a delivery device having a proximal end and a distal end adapted for forming a releasable coupling to said implantable device via the coupling means, adapted for delivering the implantable device to a designated site in a heart and manipulable at said proximal end to implant the implantable device by causing said tissue penetration means to enter tissue; and further adapted for a decoupling from the implantable device and removal after the implantation, whereby the implantable device remains at the site and modifies electrical action at and proximate the site.
Claim 22
Independent Claim
115 words
An apparatus for locally modifying electrical action within a heart, comprising: an implantable electrically inactive device including tissue penetration means and a coupling means; and a delivery device having a proximal end and a distal end adapted for forming a releasable coupling to said implantable device via the coupling means, adapted for delivering the implantable device to a designated site in a heart and manipulable at said proximal end to implant the implantable device by causing said tissue penetration means to enter tissue; and further adapted for a decoupling from the implantable device and removal after the implantation, whereby the implantable device remains at the site and modifies electrical action at and proximate the site.
Claim 23
Dependent Claim
24 words
The apparatus of claim 19 wherein: said implantable device comprises a means to deliver pharmacological agents to cardiac tissue at and proximate the site.
Claim 24
Independent Claim
52 words
An apparatus for locally modifying electrical action within a heart, comprising: a biocompatible, electrically inactive, implantable device including a means for penetrating cardiac tissue to effect an implantation of the implantable device at a designated site in a heart, to modify electrical action in the cardiac tissue at and proximate the site.
Claim 25
Independent Claim
52 words
An apparatus for locally modifying electrical action within a heart, comprising: a biocompatible, electrically inactive, implantable device including a means for penetrating cardiac tissue to effect an implantation of the implantable device at a designated site in a heart, to modify electrical action in the cardiac tissue at and proximate the site.
Claim 26
Dependent Claim
25 words
The apparatus of claim 21 wherein: the implantable device includes a non-conductive controlled release matrix for supplying a predetermined pharmacological agent to the cardiac tissue.
Claim 27
Dependent Claim
69 words
The apparatus of claim 21 wherein: the implantable device, at least over an outermost portion thereof that includes an exposed surface, is constructed of a biocompatible material selected from the group consisting of platinum black, titanium nitride, sintered platinum, roughened platinum, roughened MP35N and roughened titanium, to enhance the effective surface area of the exposed surface and thereby augment electrical coupling of the implantable device and the cardiac tissue.
Claim 28
Dependent Claim
64 words
The apparatus of claim 21 further including: a drug delivery catheter coupled to the implantable device for delivering a pharmacological agent to the implantable device, and wherein the implantable device includes a hollow core in fluid communication with the drug delivery catheter and open to an exterior of the implantable device to supply the pharmacological agent from the delivery catheter to the cardiac tissue.
Claim 29
Dependent Claim
59 words
The apparatus of claim 21 further including: a delivery catheter including a catheter distal end region coupled to the implantable device, said delivery catheter operable at a proximal end thereof to effect said implantation; and an electrode means at the catheter distal end for sensing electrical action in the cardiac tissue before said implantation, to facilitate locating the site.
Claim 30
Dependent Claim
28 words
The apparatus of claim 25 wherein: the catheter is releasably coupled to the implantable device to allow a decoupling and withdrawal of the delivery catheter after said implantation.
References Cited (Backward Citations)
US4886074A
Cited
US5246438A
Cited
US5019396A
Cited
US5002067A
Cited
US4953564A
Cited
US5282844A
Cited
US5152299A
Cited
US5411535A
Cited
US5239999A
Cited
US5281213A
Cited
US5466255A
Cited
US5295484A
Cited
US5324324A
Cited
US5342414A
Cited
US5431649A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-09-03 | 2000-03-04 | 2000-09-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-09-03 | 2004-03-04 | 2004-09-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-09-03 | 2008-03-04 | 2008-09-03 | $7700.00 | Window Closed / Lapsed |